Silvan Tuerkcan Score: 27
Analyst at
Oppenheimer,
JMP Securities
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+66.3%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
58%
7 W / 5 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
50%
5 W / 5 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 10 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 10 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
64%
7 W / 4 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
70%
7 W / 3 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 05, 2025 |
Exelixis Inc
EXEL
|
SELL |
$36.00
Est. +5%
|
$37.90 | $38.19 (Low) |
Pending
|
$53.00
-39.8%
|
| Oct 23, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$15.00
Est. +81%
|
$8.30 | $53.18 |
Target Met
|
$52.95
+538.0%
|
| Oct 06, 2025 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$33.00
Est. +65%
|
$19.96 | $28.24 |
Pending
|
$14.92
-25.3%
|
| Apr 23, 2025 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$6.00
Est. +188%
|
$2.08 | $9.75 |
Target Met
|
$5.14
+147.1%
|
| Jan 27, 2025 |
Exelixis Inc
EXEL
|
BUY |
$41.00
Est. +27%
|
$32.38 | $49.40 |
Target Met
|
$53.00
+63.7%
|
| Nov 18, 2024 |
enGene Holdings Inc
ENGN
|
BUY |
$18.00
Est. +172%
|
$6.61 | $11.13 |
Miss
|
$1.62
-75.5%
|
| Oct 14, 2024 |
Benitec Biopharma Inc
BNTC
|
BUY |
$16.00
Est. +47%
|
$10.86 | $17.15 |
Target Met
|
$11.33
+4.3%
|
| Oct 14, 2024 |
Benitec Biopharma Inc
BNTC
|
BUY |
$18.00
Est. +66%
|
$10.86 | $17.15 |
Miss
|
$11.33
+4.3%
|
| Sep 10, 2024 |
Oracle Corp.
ORCL
|
SELL |
$80.00
Est. +49%
|
$156.38 | $118.86 (Low) |
Miss
|
$192.64
-23.2%
|
| Aug 07, 2024 |
Exelixis Inc
EXEL
|
BUY |
$29.00
Est. +24%
|
$23.45 | $49.40 |
Target Met
|
$53.00
+126.0%
|
| Jul 31, 2024 |
Macrogenics Inc
MGNX
|
BUY |
$8.00
Est. +52%
|
$5.25 | $5.10 |
Miss
|
$4.13
-21.3%
|
| Apr 25, 2024 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$17.00
Est. +79%
|
$9.50 | $10.16 |
Miss
|
$1.48
-84.4%
|
Exelixis Inc
EXEL
Nov 05, 2025
Signal & Target
SELL
$36.00
Start Price
$37.90
Best Price (1Y)
$38.19
Current Price
$53.00
Return
-39.8%
Terns Pharmaceuticals Inc
TERN
Oct 23, 2025
Signal & Target
BUY
$15.00
Start Price
$8.30
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+538.0%
Intellia Therapeutics Inc
NTLA
Oct 06, 2025
Signal & Target
BUY
$33.00
Start Price
$19.96
Best Price (1Y)
$28.24
Current Price
$14.92
Return
-25.3%
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Apr 23, 2025
Signal & Target
BUY
$6.00
Start Price
$2.08
Best Price (1Y)
$9.75
Current Price
$5.14
Return
+147.1%
Exelixis Inc
EXEL
Jan 27, 2025
Signal & Target
BUY
$41.00
Start Price
$32.38
Best Price (1Y)
$49.40
Current Price
$53.00
Return
+63.7%
enGene Holdings Inc
ENGN
Nov 18, 2024
Signal & Target
BUY
$18.00
Start Price
$6.61
Best Price (1Y)
$11.13
Current Price
$1.62
Return
-75.5%
Benitec Biopharma Inc
BNTC
Oct 14, 2024
Signal & Target
BUY
$16.00
Start Price
$10.86
Best Price (1Y)
$17.15
Current Price
$11.33
Return
+4.3%
Benitec Biopharma Inc
BNTC
Oct 14, 2024
Signal & Target
BUY
$18.00
Start Price
$10.86
Best Price (1Y)
$17.15
Current Price
$11.33
Return
+4.3%
Oracle Corp.
ORCL
Sep 10, 2024
Signal & Target
SELL
$80.00
Start Price
$156.38
Best Price (1Y)
$118.86
Current Price
$192.64
Return
-23.2%
Exelixis Inc
EXEL
Aug 07, 2024
Signal & Target
BUY
$29.00
Start Price
$23.45
Best Price (1Y)
$49.40
Current Price
$53.00
Return
+126.0%
Macrogenics Inc
MGNX
Jul 31, 2024
Signal & Target
BUY
$8.00
Start Price
$5.25
Best Price (1Y)
$5.10
Current Price
$4.13
Return
-21.3%
Acrivon Therapeutics Inc
ACRV
Apr 25, 2024
Signal & Target
BUY
$17.00
Start Price
$9.50
Best Price (1Y)
$10.16
Current Price
$1.48
Return
-84.4%